ASCLEPIX THERAPEUTICS LLC has a total of 19 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are SENDAI BISEIBUTSU KENKYUSHO, JIANGSU AIDEA PHARMACEUTICAL CO LTD and AFFIRIS FORSCHUNGS & ENTWICKLUNGS GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | United States | 2 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Green Jordan J | 13 |
#2 | Popel Aleksander S | 13 |
#3 | Pandey Niranjan B | 13 |
#4 | Bressler Eric M | 8 |
#5 | Shmueli Ron B | 7 |
#6 | Mirando Adam | 7 |
#7 | Jordan J Green | 3 |
#8 | Aleksander S Popel | 3 |
#9 | Niranjan B Pandey | 3 |
#10 | Pandey Niranjan | 2 |
Publication | Filing date | Title |
---|---|---|
US2019225670A1 | Compounds and methods for activating tie2 signaling | |
KR20180081608A | Anti-angiogenesis, anti-lymphangiogenesis, and peptides and nanoparticle preparations with anti-edema properties |